Scientific Instrument Company Launches at the Speed of Light DENVER, Jan. 6, 2021 /PRNewswire/ — Today, Exum Instruments, Inc., a Denver-based company building next generation scientific instruments and software ecosystems to increase the speed and breadth of materials development and discovery, has announced two major milestones. Achieved its 2020 commercial sales goals Incorporated only three and half years […]

BEVERLY, Mass.– Adeptrix Corp, the developer of advanced bioanalytical tools based on its proprietary BAMS™ (Bead Assisted Mass Spectrometry) platform technology, today announced the closing of its Series A investment round with Bruker Corporation as a new minority investor. The proceeds will go toward accelerating commercialization of multiple BAMS products and establishing custom BAMS assay […]

Proposed transaction builds on both companies’ strategic R&D partnership Strengthens Sartorius position in downstream bioprocessing Göttingen — The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until […]

GAINESVILLE, Fla. and CHAPEL HILL, N.C. — JUNO Metabolomics today announced the release of the JUNO Viral Surveillance Platform based on its proprietary AI-Based Informatics System. The JUNO Viral Surveillance Platform allows remote testing anywhere in the world for viruses or virus mutations in approximately 15 minutes using a basic saliva sample and a portable mass spectrometer (“MALDI-MS”). JUNO uses the […]

Cash and Stock Transaction Valued at Approximately $8.0 Billion THOUSAND OAKS, Calif. and ARLINGTON, Va. – Teledyne Technologies Incorporated (NYSE:TDY) (“Teledyne”) and FLIR Systems, Inc. (NASDAQ:FLIR​​​​​) (“FLIR”) jointly announced today that they have entered into a definitive agreement under which Teledyne will acquire FLIR in a cash and stock transaction valued at approximately $8.0 billion. […]

BOSTON — 908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the closing of its upsized initial public offering of shares of its common stock, with 7,475,000 shares offered and sold by the Company at a public offering price of $20.00 per share, which […]

License for the use of the Affimer platform for affinity purification applications Cambridge and Wetherby, UK: Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a license agreement with Astrea Bioseparations (“Astrea”) for the use of the […]

GMP-scale system enables advanced purification of peptides, oligos, RNA, and dsDNA based therapies and vaccines on a continuous basis. Allentown, PA — A state-of-the-art lab, with a focus on developing continuous purification technologies, that was inaugurated in November 2019 will be home to the first-of-a-kind continuous HPLC. Named “Kyoto Works,” the 2,600m2 facility is owned by YMC […]

MENLO PARK, Calif. and CAMBRIDGE, United Kingdom — Gamma Biosciences, a life sciences tools platform created by KKR, today announced a licensing agreement between Astrea Bioseparations, a leader in affinity chromatography and bioseparations, and Avacta, a developer of innovative cancer therapies and diagnostics based on proprietary Affimer® and preCISION™ platforms. The licensing agreement gives Astrea access […]

All Good Things Come in Threes: KNAUER supports the Berlin City Mission’s help for the homeless, the Plan International children’s charity and the UN Refugee Aid It’s uncomfortable outside, dark and winter! While many of us are sitting well sheltered in the warm, many homeless, sick and displaced people are having a really hard time. […]